CSIMarket Company Name, Ticker, Suppliers, else..
 
Revvity Inc  (NYSE: RVTY)
 
Price: $130.2200 $-0.41 -0.314%
Day's High: $131.6999969482422 Week Perf: 1.2 %
Day's Low: $ 129.59 30 Day Perf: 13.99 %
Volume (M): 1,167,592 52 Wk High: $ 133.00
Volume (M$): $ 0 52 Wk Avg: $99.96
Open: $130.03 52 Wk Low: $81.22



 Market Capitalization (Millions $) 14,536
 Shares Outstanding (Millions) 112
 Employees 11,000
 Revenues (TTM) (Millions $) 2,912
 Net Income (TTM) (Millions $) 238
 Cash Flow (TTM) (Millions $) -132
 Capital Exp. (TTM) (Millions $) 70

Business Description




   Company Address: 77 4th Avenue, Waltham, 2451 MA
   Company Phone Number: 663-6900   Stock Exchange / Ticker: NYSE RVTY


Customers Net Income grew by RVTY's Customers Net Profit Margin grew to

108.06 %
17.04 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
A   -1.94%    
BIO   -0.41%    
ILMN        1.22% 
MTD   -3.81%    
QTRX        1.89% 
TXG        1.8% 
• View Complete Report
   



Business Update

Revvity Expands Scientific Software Capabilities and Genomic Diagnostic Solutions Through Strategic Acquisitions and ...

Published Mon, Nov 10 2025 2:49 PM UTC

Revvity’s Strategic Moves to Enhance Scientific Software and Genomic Diagnostics WALTHAM, Mass. In an ambitious bid to bolster its position in the analytical and genomic landscapes, Revvity, Inc. (NYSE: RVTY), has announced significant operational advancements through targeted acquisitions and strategic collaborations. The company is steadfastly committed to creating a s...
Business Update

Navigating Dual Currents Revvity Set for Key Investor Conferences Amid Market Challenges,

Published Wed, Oct 29 2025 7:01 PM UTC

In the ever-evolving landscape of healthcare technology, Revvity, Inc. (NYSE: RVTY), headquartered in Waltham, Massachusetts, is set to make a noteworthy appearance at several prestigious investor conferences in the coming months. The company has announced that Max Krakowiak, its senior vice president and chief financial officer, will present at the UBS Global Healthcare Con...
Business Update

Revvity Innovates with Strategic Advances in AI-Enhanced Gene Editing, Automated Specialty Testing, and TB Detection

Published Mon, Sep 22 2025 2:10 PM UTC

Revvity s Latest Developments: Enhancing Precision in Healthcare WALTHAM, Mass. Revvity, Inc. (NYSE: RVTY) stands at the forefront of biotechnology innovation with a series of strategic advances aimed at enhancing the precision and efficiency of healthcare technologies. AI-Enhanced Base Editing Collaboration with Profluent Revvity recently announced a strategic partnership w...
Dividend

Revvity Declares Quarterly Dividend, Emphasizing Commitment to Innovation and Shareholder Value in Health Sciences,

Published Fri, Apr 25 2025 6:55 AM UTC

Revvity Declares Quarterly Dividend: A Sign of Steady Progress in Health SciencesWALTHAM, Mass. In a notable development for investors and stakeholders alike, the Board of Directors of Revvity (NYSE: RVTY) announced today the declaration of a regular quarterly dividend of $0.07 per share of common stock. This dividend will be payable on August 8, 2025, to all shareholders ...
Business Update

Revvitys Dual Odyssey Pioneering Measles Diagnostics & Navigating Financial Horizons,

Published Mon, Mar 3 2025 7:02 PM UTC

From Virus Vigilance to Financial Resilience: Revvity s Dual Path of Innovation In an era where healthcare precision and profitability walk hand-in-hand, Revvity, Inc. (NYSE: RVTY) strides forward as a formidable player in both arenas. The Massachusetts-based company recently announced a pivotal advancement with its subsidiary, EUROIMMUN, unveiling the CE-marked Anti-Measles...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 62.91
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 4.99
Price to Sales (Expected) -
Price to Book 2.01
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.67
Working Capital Ratio 1.52
Leverage Ratio (MRQ) 0.67
Total Debt to Equity 0.53
Interest Coverage (TTM) -
Debt Coverage (TTM) 0.25

Per Share Current
Earnings (TTM) 2.07 $
Revenues (TTM) 26.08 $
Cash Flow (TTM) -
Cash 9.16 $
Book Value 64.76 $
Dividend (TTM) 0.28 $

Efficiency Current
Revenue per Employee (TTM) 264,710
Net Income per Employee (TTM) 21,596
Receivable Turnover Ratio (TTM) 4.12
Inventory Turnover Ratio (TTM) 2.98
Asset Turnover Ratio (TTM) 0.24

Profitability Ratios Current
Gross Margin (MRQ) 57.13 %
Operating Margin (MRQ) 12.24 %
Net Margin (MRQ) 7.1 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 8.97 %

Management Effectiveness Current
Return On Assets (TTM) 1.97 %
Return On Investment (TTM) 2.21 %
Return On Equity (TTM) 3.27 %
Dividend Yield 0.22 %
Pay out Ratio (TTM) 13.53 %



Revvity Inc's Segments
Product    162.38 % of total Revenue
Service    35.07 % of total Revenue
Life Sciences    98.75 % of total Revenue
Diagnostics    98.71 % of total Revenue
Americas    87.92 % of total Revenue
Europe    61.96 % of total Revenue
Asia    47.57 % of total Revenue
Reportable Segment Revenue    197.46 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.